1022150-57-7Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1BCZUAADEACICHN-UHFFFAOYSA-NSGX-523 is a member of the class of triazolopyridazines that is 6-(1-methylpyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazine-3-thiol in which the thiol hydrogen is replaced by a quinolin-6-yl group. It has a role as a nephrotoxic agent and a c-Met tyrosine kinase inhibitor. It is a member of pyrazoles, a member of quinolines, an aryl sulfide, a triazolopyridazine and a biaryl.
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
SGX523 is selective inhibitor of the receptor tyrosine kinase MET. MET is implicated in development and progression of cancer. SGX523 ihibits MET autophosphorylation and signalling, as well as activates cysteine-aspartic acid protease 3 (caspase 3), an enzyme which is part of the apoptosis signalling cascade.
용도SGX523 is a novel, ATP-competitive kinase inhibitor.
정의ChEBI: A member of the class of triazolopyridazines that is 6-(1-methylpyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazine-3-thiol in which the thiol hydrogen is replaced by a quinolin-6-yl group.
불러오는 중…
1022150-57-7DTXSID70647300CHEMBL1236107CHEBI:90624